Losartan Potassium Tablets, 50 Mg Tablet
Product Images NDC 63629-9192

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 50 Mg (NDC 63629-9192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

A line graph comparing the percentage of patients with a primary endpoint over a 66-month study period for Atenolol and Losartan Potassium. The x-axis represents study months, while the y-axis shows the percentage of patients. The graph includes an adjusted risk reduction of 13% with a p-value of 0.021, indicating statistical significance.*

FDA Label Image

Figure 2 (Figure2)

A line graph comparing the percentage of patients with fatal/non-fatal strokes over time between Atenolol (dotted line) and Losartan Potassium (solid line). The x-axis represents study months (0 to 66), and the y-axis shows the percentage of affected patients (0 to 8%). The graph includes a note of adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Figure 3 (Figure3)

A forest plot showing primary endpoint events and stroke (fatal/non-fatal) rates within demographic subgroups comparing Losartan and Atenolol. The chart displays event rates, hazard ratios with 95% confidence intervals, and indicates whether results favor Losartan or Atenolol for groups based on age, gender, race, ISH, diabetes, and history of cardiovascular disease.*

FDA Label Image

Figure 4.jpg (Figure4)

A line graph comparing the percentage of patients with an event over time (up to 48 months) for Losartan Potassium versus placebo. The graph shows risk reduction data with Losartan Potassium and includes a p-value indicating statistical significance.*

FDA Label Image

Label (Lbl636299192)

Label for Losartan Potassium Tablets, USP 50 mg, an oral human prescription drug. The label indicates a package of 1000 tablets with the product NDC 63629-9192-01. It is manufactured by Jubilant Cadista Pharmaceuticals Inc. and repackaged by Bryant Ranch Prepack, Inc. The label includes storage instructions, dosage note, and a pharmacist dispensing reminder. The BRP Pharmaceuticals logo is displayed.*

FDA Label Image

Losartan Potassium, Usp (Structure)

Chemical structure of losartan potassium showing its molecular components including a chlorinated pyrimidine ring, biphenyl group, and potassium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.